Search Results for: CLINICAL TRIALS Its Time to
Articles
June 18, 2012
KineMed Announces Biomarker Discovery Collaboration With Major Pharma Co. June 18, 2012
KineMed, Inc. recently announced a multi-year R&D collaboration with GlaxoSmithKline plc (GSK) that will apply KineMed's proprietary biomarker discovery platform...
June 4, 2012
6/6/2012 June 4, 2012
Royer Biomedical Receives Approval to Test Polymer Delivery System Royer Biomedical, Inc. (RBI) recently announced it received FDA approval to...
May 28, 2012
5/30/2012 May 28, 2012
Takeda's MAA Filing Triggers a $10-Million MilestoneFuriex Pharmaceuticals, Inc. recently confirmed that Takeda Global Research & Development Centre (Europe) Ltd....
May 28, 2012
Tranzyme Pharma & Norgine Announce Top-Line Data May 28, 2012
Tranzyme Pharma and Norgine B.V. recently announced top-line results of the primary analysis of ULISES 008, the second of two...
May 20, 2012
5/23/2012 May 20, 2012
Agilent to Acquire Cancer Diagnostic Company for $2.2 Billion Agilent Technologies Inc. and EQT, the Sweden-based private equity group, recently...
May 14, 2012
5/16/2012 May 14, 2012
Mucosis Announces Positive Data for Mimopath Platform Mucosis B.V. recently announced Phase I clinical data providing proof-of-concept that Mimopath-based mucosal...
May 6, 2012
5/9/2012 May 6, 2012
Caisson Biotech Enters Potential $100 Million Agreement Caisson Biotech, L.L.C. recently announced it has entered into a development and license...
April 29, 2012
5/1/2012 April 29, 2012
3M DDS to Enhance Manufacturing Capabilities 3M Drug Delivery Systems recently announced the expansion of the pressurized metered dose inhaler (pMDI) fill...
April 15, 2012
4/17/2012 April 15, 2012
Ei Increases Capabilities Through New Partnership Ei, A Pharmaceutical SolutionWorks, recently announced a new partnership with KeraNetics. Ei has begun...
April 15, 2012
QRxPharma Successfully Completes Phase I Studies April 15, 2012
QRxPharma recently announced successful completion of two Phase I studies in healthy volunteers for MoxDuo CR, a controlled-release Dual-Opioid utilizing...
March 29, 2012
4/3/2012 March 29, 2012
Aptar Pharma's Device Delivers INSYS Therapeutics' Drug Aptar Pharma recently announced INSYS Therapeutics' SUBSYS, which uses an Aptar Pharma Sublingual...
March 15, 2012
3/20/2012 March 15, 2012
Connell Brothers Signs Agreement With World's Top Chemical Company Connell Brothers Australasia recently announced it was appointed by BASF Australia,...
February 12, 2012
2/14/2012 February 12, 2012
Bend Research Signs License Agreement With Eli Lilly & Company Bend Research Inc., a leading independent drug formulation development and...
February 5, 2012
2/7/2012 February 5, 2012
Foster Analytical Services Speed Time to Market for Drug Delivery Formulations Foster Delivery Science, a business unit for Foster Corporation,...
January 29, 2012
1/31/2012 January 29, 2012
Amgen to Buy Micromet for $1.16 Billion Amgen and Micromet, Inc. recently announced the companies have entered into a definitive merger...
January 22, 2012
1/24/2012 January 22, 2012
Dishman Pharmaceuticals & Chemicals Acquires Creapharm Parenterals Switzerland-based Carbogen Amcis AG, a leading pharmaceutical process development and API manufacturing company,...
January 4, 2012
1/10/2012 January 4, 2012
Particle Sciences Expands Program With Additional Proprietary Modeling Capabilities Particle Sciences recently announced it has added a third computational module...
December 18, 2011
12/20/2011 December 18, 2011
Enlight Biosciences Forms Lucrative New Partnerships Enlight Biosciences LLC recently announced today it has formed new partnerships with AstraZeneca and...
December 18, 2011
ProJect Pharmaceutics Introduces Predictive Formulation Analytics for Optimized Biopharmaceutical Formulations December 18, 2011
Protein drug formulation is particularly challenging due to structural complexity and instability. The biological activity of most recombinant proteins emanates...
December 11, 2011
12/13/2011 December 11, 2011
Abbott Laboratories Spends $400 Million on Development Deal Abbott Laboratories and Reata Pharmaceuticals recently announced they have entered into a worldwide...
